Biparametric MRI of the prostate

Area of Science:

• Radiology
• Oncology
• Medical Imaging

Background:

• Multiparametric MRI (mpMRI) is standard for prostate cancer (PCa) detection, but has limitations.
• Biparametric MRI (bpMRI) combines T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) as a potential alternative.
• bpMRI addresses mpMRI's cost, time, contrast agent, and equivocal lesion management challenges.

Purpose of the Study:

• To review the current knowledge on bpMRI for suspicious PCa detection.
• To propose a simplified bpMRI-based scoring system for PCa management.
• To enhance communication between radiologists and urologists regarding PCa diagnosis.

Main Methods:

• Review of existing literature on bpMRI in prostate cancer diagnosis.
• Analysis of the role of DWI as the dominant sequence in bpMRI.
• Development of a simplified PI-RADS v2-based scoring system for bpMRI.

Main Results:

• bpMRI demonstrates clinical results comparable to mpMRI for PCa detection and localization.
• DWI is identified as the primary sequence for detecting suspicious PCa in both prostate zones.
• A standardized bpMRI scoring system can simplify PCa management and improve clinical decision-making.

Conclusions:

• bpMRI is a viable and efficient alternative to mpMRI for prostate cancer assessment.
• A simplified bpMRI scoring system can aid in the management of suspicious PCa categories.
• bpMRI facilitates improved communication and standardized reporting in prostate cancer diagnostics.